Danish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
chemotherapy/opkast
Linket gemmes på udklipsholderen
Side 1 fra 74 resultater
Method of controlling emesis caused by cisplatin in cancer chemotherapy
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION
1. Field of Invention
Cisplatin (cis-dichlorodiammine platinum II) is one of the more effective drugs used in cancer chemotherapy; however, the resulting violent emesis interferes with acceptance of therapy by the patient. This invention relates to an improvement in the
Compositions comprising lipophilic extracts of Zingiber officinale and Echinacea angustifolia for the prevention and treatment of gastro-oesophageal reflux and chemotherapy-induced emesis
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
This application is a U.S. national stage of PCT/EP2010/000,204 filed on
Jan. 15, 2010 which claims priority to and the benefit of Italian Application No. MI200,9000,049 filed on Jan. 20, 2009, the contents of which are incorporated herein by reference.
SUMMARY OF THE INVENTION
The present invention
Compositions comprising lipophilic extracts of Zingiber officinale and Echinacea angustifolia for the prevention and treatment of gastro-oesophageal reflux and chemotherapy-induced emesis
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
SUMMARY OF THE INVENTION
The present invention relates to compositions consisting of an association of lipophilic extracts of Zingiber officinale and Echinacea angustifolia, which are useful for the prevention and treatment of oesophageal reflux and chemotherapy-induced emesis.
PRIOR ART
Cancer of
Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
This application is a .sctn.371 national stage of PCT International Application No. PCT/EP2011/058224, filed May 20, 2011, claiming priority of European Patent Application EP 10382136.9, filed May 21, 2010, the contents of all of which are hereby incorporated by reference into this
Compositions and methods for treating centrally mediated nausea and vomiting
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention relates to the use of centrally acting NK.sub.1 antagonists to treat nausea and vomiting, particular nausea and vomiting induced by highly emetogenic chemotherapy, and to the treatment of such nausea and vomiting over multiple consecutive days. The
Compositions and methods for treating centrally mediated nausea and vomiting
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention relates to the use of centrally acting NK.sub.1 antagonists to treat nausea and vomiting, particular nausea and vomiting induced by highly emetogenic chemotherapy, and to the treatment of such nausea and vomiting over multiple consecutive days. The
Compositions and methods for treating centrally mediated nausea and vomiting
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention relates to the use of centrally acting NK.sub.1 antagonists to treat nausea and vomiting, particular nausea and vomiting induced by highly emetogenic chemotherapy, and to the treatment of such nausea and vomiting over multiple consecutive days. The
Compositions and methods for treating centrally mediated nausea and vomiting
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention relates to the use of centrally acting NI.sub.1 antagonists to treat nausea and vomiting, particular nausea and vomiting induced by highly emetogenic chemotherapy, and to the treatment of such nausea and vomiting over multiple consecutive days. The
Compositions and methods for treating centrally mediated nausea and vomiting
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention relates to the use of centrally acting NK.sub.1 antagonists to treat nausea and vomiting, particular nausea and vomiting induced by highly emetogenic chemotherapy, and to the treatment of such nausea and vomiting over multiple consecutive days. The
Pharmaceutical compositions for headache, migraine, nausea and emesis
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention relates to the use of S-alkylisothiouronium derivatives, including, but not limited to, S-ethylisothiouronium diethylphosphate, for the prevention or treatment of headache, including but not limited to migraine, and for the prevention or treatment of
Pharmaceutical compositions for headache, migraine, nausea and emesis
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention relates to the use of S-alkylisothiouronium derivatives, including, but not limited to, S-ethylisothiouronium diethylphosphate, for the prevention or treatment of headache, including but not limited to migraine, and for the prevention or treatment of
Combinations of amisulpride and another anti-emetic for treating nausea and vomiting
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
RELATED APPLICATIONS
This application is a U.S. National Phase application, filed under 35 U.S.C. .sctn. 371(c), of International Application No. PCT/GB2016/050998, filed on Apr. 11, 2016, which claims the benefit of and priority to United Kingdom Patent Application No. 1506116.1, filed on Apr. 10,
Methods for treating emesis and nausea using optically pure R(+) ondansetron
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION
This invention relates to novel compositions of matter containing optically pure R(+) ondansetron. These novel compositions have potent antiemetic activity and are useful in ameliorating the nausea and vomiting otherwise induced by cancer chemotherapeutic agents and
Delivery of a chemotherapy agent across the blood-brain barrier
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention relates in general to methods for delivering therapeutic compounds across the blood-brain barrier of patients, and more particularly to the use of cannabinoids coupled to a chemotherapy agent for transport across the blood-brain barrier.
BACKGROUND OF THE
Amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION
The present invention provides a prodrug of propofol and crystalline forms thereof, methods of making the propofol prodrug and crystalline forms thereof, pharmaceutical compositions of the propofol prodrug and crystalline forms thereof, methods of using the propofol
Den mest komplette database med medicinske urter understøttet af videnskab
- Arbejder på 55 sprog
- Urtekurer, der understøttes af videnskab
- Urtegenkendelse ved billede
- Interaktivt GPS-kort - tag urter på stedet (kommer snart)
- Læs videnskabelige publikationer relateret til din søgning
- Søg medicinske urter efter deres virkninger
- Organiser dine interesser og hold dig opdateret med nyhedsundersøgelser, kliniske forsøg og patenter
Skriv et symptom eller en sygdom, og læs om urter, der kan hjælpe, skriv en urt og se sygdomme og symptomer, den bruges mod.
* Al information er baseret på offentliggjort videnskabelig forskning
